[go: up one dir, main page]

WO2016013921A3 - Novel molecules derived from phosphorylated 2-phenyl-imidazolines, having high imidazoline ring stability and a high level of effectiveness as corrosion inhibitors - Google Patents

Novel molecules derived from phosphorylated 2-phenyl-imidazolines, having high imidazoline ring stability and a high level of effectiveness as corrosion inhibitors Download PDF

Info

Publication number
WO2016013921A3
WO2016013921A3 PCT/MX2015/000131 MX2015000131W WO2016013921A3 WO 2016013921 A3 WO2016013921 A3 WO 2016013921A3 MX 2015000131 W MX2015000131 W MX 2015000131W WO 2016013921 A3 WO2016013921 A3 WO 2016013921A3
Authority
WO
WIPO (PCT)
Prior art keywords
imidazolines
phenyl
corrosion inhibitors
phosphorylated
effectiveness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/MX2015/000131
Other languages
Spanish (es)
French (fr)
Other versions
WO2016013921A2 (en
Inventor
J. Guadalupe TÉLLES PADILLA
Luis Ernesto ELIZALDE HERRERA
Jorge Félix ESPINOZA MUÑOZ
Gregorio Cadenas Pliego
Ana María LLAGUNO RUEDA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polioles SA de CV
Centro de Investigacion en Quimica Aplicada CIQA
Original Assignee
Polioles SA de CV
Centro de Investigacion en Quimica Aplicada CIQA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polioles SA de CV, Centro de Investigacion en Quimica Aplicada CIQA filed Critical Polioles SA de CV
Publication of WO2016013921A2 publication Critical patent/WO2016013921A2/en
Publication of WO2016013921A3 publication Critical patent/WO2016013921A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Abstract

The invention relates to a process involving a reaction between derivatives of 2-phenyl-2-imidazolines or compounds thereof substituted at position 1 with 2-aminoethyl or 2-hydroxyethyl groups with mono or biphosphates of dodecyl in the presence of aromatic solvents or mixtures of aromatic compounds having boiling points between 100 and 200°C, the derived phosphoramides and phosphates being strong corrosion inhibitors.
PCT/MX2015/000131 2014-07-25 2015-09-25 Novel molecules derived from phosphorylated 2-phenyl-imidazolines, having high imidazoline ring stability and a high level of effectiveness as corrosion inhibitors Ceased WO2016013921A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2014009044A MX2014009044A (en) 2014-07-25 2014-07-25 Novel molecules derived from phosphorylated 2-phenyl-imidazolines , having high imidazoline ring stability and a high level of effectiveness as corrosion inhibitors.
MXMX/A/2014/009044 2014-07-25

Publications (2)

Publication Number Publication Date
WO2016013921A2 WO2016013921A2 (en) 2016-01-28
WO2016013921A3 true WO2016013921A3 (en) 2016-06-09

Family

ID=55163927

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MX2015/000131 Ceased WO2016013921A2 (en) 2014-07-25 2015-09-25 Novel molecules derived from phosphorylated 2-phenyl-imidazolines, having high imidazoline ring stability and a high level of effectiveness as corrosion inhibitors

Country Status (2)

Country Link
MX (1) MX2014009044A (en)
WO (1) WO2016013921A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
AU2018326705A1 (en) 2017-08-30 2020-03-05 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
WO2020018949A2 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554090A (en) * 1984-03-09 1985-11-19 Jones L W Combination corrosion/scale inhibitor
RO92694A2 (en) * 1987-11-14 1987-11-30 Centrul De Chimie,Ro PROCESS FOR PREPARING 1- (0,0-DIALKYLPHOSPHOS-PHORYL) -2-ALKYL) -2-IMIDAZOLINES
US4842716A (en) * 1987-08-13 1989-06-27 Nalco Chemical Company Ethylene furnace antifoulants
EP1333108A2 (en) * 2002-02-01 2003-08-06 LAMBERTI S.p.A. Corrosion inhibitors for the petroleum industry

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554090A (en) * 1984-03-09 1985-11-19 Jones L W Combination corrosion/scale inhibitor
US4842716A (en) * 1987-08-13 1989-06-27 Nalco Chemical Company Ethylene furnace antifoulants
RO92694A2 (en) * 1987-11-14 1987-11-30 Centrul De Chimie,Ro PROCESS FOR PREPARING 1- (0,0-DIALKYLPHOSPHOS-PHORYL) -2-ALKYL) -2-IMIDAZOLINES
EP1333108A2 (en) * 2002-02-01 2003-08-06 LAMBERTI S.p.A. Corrosion inhibitors for the petroleum industry

Also Published As

Publication number Publication date
WO2016013921A2 (en) 2016-01-28
MX2014009044A (en) 2016-01-25

Similar Documents

Publication Publication Date Title
SG10201809518QA (en) Processes of preparing a jak1 inhibitor and new forms thereto
CA3010752A1 (en) Inhibitors of the pd-1/pd-l1 protein/protein interaction
TW201613886A (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
PH12016501633B1 (en) Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
CA2983453A1 (en) Naphthyridine compounds as jak kinase inhibitors
HK1252378A1 (en) Tyrosine kinase inhibitors
PH12016501388A1 (en) Heteroaryls and uses thereof
HK1246286A1 (en) Lrrk2 inhibitors and methods of making and using the same
HK1263287A1 (en) Antifungal compounds and processes for making
WO2016044463A3 (en) Mk2 inhibitors and uses thereof
EP3290419A4 (en) Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
HK1199025A1 (en) Benzyl sulfonamide derivatives useful as mogat - 2 inhibitors
WO2018029711A3 (en) Process for the preparation of venetoclax
WO2016040347A3 (en) Microrna inhibitor system and methods of use thereof
MX2015000980A (en) Aryl lactam kinase inhibitors.
WO2018218197A3 (en) Tetrahydropyrido[4,3-d]pyrimidine inhibitors of atr kinase
MX2016009355A (en) Aryl lactam kinase inhibitors.
HK1246299A1 (en) Process of making cenicriviroc and related analogs
WO2016038628A3 (en) A process for preparing olodaterol and intermediates thereof
WO2016013921A3 (en) Novel molecules derived from phosphorylated 2-phenyl-imidazolines, having high imidazoline ring stability and a high level of effectiveness as corrosion inhibitors
MX369661B (en) Biocidic microcapsules.
WO2015195950A8 (en) Lmp7 inhibitors
WO2016142819A3 (en) Novel process for the preparation of ranolazine
WO2016164295A3 (en) Fused pyridines as adaptor associated kinase 1 (aak1) inhibitors
PH12019502046A1 (en) Pyrrolotriazine derivatives as kinase inhibitor

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15824505

Country of ref document: EP

Kind code of ref document: A2